KannaLife

Kannalife Sciences Inc.

Company type	Private subsidiary
Industry	Bio-pharmaceutical, Phyto-medicine
Founded	2010 (2010)
Founder	Dean Petkanas, Thoma Kikis
Headquarters	Doylestown , United States
Products	Therapeutic solutions addressing oxidative stress, immune system modulation, neuroprotection; KLS-13019
Owner	Neuropathix, Inc.
Parent	Neuropathix, Inc.
Website	www.kannalife.com

Kannalife Sciences Inc. operates as a private subsidiary of Neuropathix, Inc. and is a bio-pharmaceutical and phyto-medicine enterprise headquartered in Doylestown, Pennsylvania. The company was founded in 2010 by Dean Petkanas and Thoma Kikis with the mission to create innovative therapeutic solutions addressing oxidative stress, immune system modulation, and neuroprotection.

History

In 2011, Kannalife obtained an Exclusive License from the National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the patent titled "Cannabinoids as Antioxidants and Neuroprotectants" (patent ).

A significant milestone occurred in 2021 when Kannalife was awarded a non-dilutive grant totaling $2.97 million over three years by the National Institute of Neurological Disorders and Stroke (NINDS) through the NIH HEAL Initiative. This funding supports the advancement of KLS-13019 aimed at managing neuropathic pain. Subsequently, in 2024, The Michael J. Fox Foundation granted $1.49 million to facilitate preclinical studies of KLS-13019 focusing on Parkinson’s disease by targeting neuroinflammation and mitochondrial dysfunction.

Research and development activities are conducted at the Pennsylvania Biotechnology Center of Bucks County, with therapeutic programs concentrating on conditions such as chemotherapy-induced peripheral neuropathy, hepatic encephalopathy, Parkinson’s disease, mild traumatic brain injury, and chronic traumatic encephalopathy (CTE).

Kannalife’s cannabinoid-based research related to concussion and CTE has been featured in Sports Illustrated, highlighting its innovative approach within this domain.

External links

Patent US 6630507

https://www.kannalife.com/